Kasabach–Merritt phenomenon
Kasabach-Merritt Phenomenon (KMP) is a potentially life-threatening condition characterised by thrombocytopenic consumptive coagulopathy. KMP is almost exclusively associated with two uncommon vascular tumours, Kaposiform haemangioendotheliomas (KHE) and tufted angiomas (TA). It is clinically charac...
Main Authors: | Sanjay Singh, Neetu Bhari, Rubina Jassi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Paediatric Dermatology |
Subjects: | |
Online Access: | http://www.ijpd.in/article.asp?issn=2319-7250;year=2019;volume=20;issue=4;spage=295;epage=301;aulast=Singh |
Similar Items
-
Commentary: Transarterial Embolization in Neonatal Kasabach–Merritt Syndrome
by: Huaijie Wang, et al.
Published: (2022-06-01) -
Comprehensive Therapy for Infant Vascular Tumor Associated With Kasabach–Merritt Phenomenon—Single-Center Primary Experience
by: Xiaoting Sun, et al.
Published: (2022-06-01) -
Sirolimus for Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Neonate
by: Trevor B. Cabrera, et al.
Published: (2020-10-01) -
Vincristine, aspirin, and prednisolone therapy in Kasabach–Merritt phenomenon: Response in 2 cases
by: Shikha Gupta, et al.
Published: (2019-01-01) -
Prenatal detection of Kaposiform Hemangioendothelioma with Kasabach–Merritt phenomenon: a case report
by: Vinay Maurya, et al.
Published: (2023-05-01)